Skip to content

Clinical trials

Completed Phase 2/3 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 2/3 Status: Completed Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20042
20062
20072
20081
20092
20123
20132
20141
20153
20161
20173
20182
20192
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
VA Office of Research and Development3
Anavex Life Sciences Corp.2
Avid Radiopharmaceuticals2
University of Southern California2
University of Wisconsin, Madison2
Annovis Bio Inc.1
Axsome Therapeutics, Inc.1
Cerecin1
Charite University, Berlin, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease32
Dementia9
Cognitive Dysfunction3
Amyloid Neuropathies, Familial2
Amyloidosis2
Polyneuropathies2
Psychomotor Agitation2
Brain Diseases1
Cerebral Small Vessel Diseases1
Hypertension1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.